Interleukin-17 mRNA expression and serum levels in Behçet’s disease

Increased expression of interleukin 17 in inflammatory bowel disease

Sanae Fujino · Gut · 2002 · 1.7K citations · Full text

Life Sciences, Immunology, Pathology +17

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

Fereydoun Davatchi, Samir H. Assaad‐Khalil, Kenneth Calamia et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 1.4K citations · Full text

Medicine, Internal Medicine, Clinical Classification Systems +10

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Iain B. McInnes, Philip J. Mease, Bruce Kirkham et al. · The Lancet · 2015 · 850 citations

Life Sciences, Immunology, Pharmacotherapy +15

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

Ahjoku Amadi‐Obi, Cheng‐Rong Yu, Xuebin Liu et al. · Nature Medicine · 2007 · 849 citations

Medicine, Immunology, Pathology +12